This inventor holds 10 USPTO granted patents. Top assignees: Synthelabo, Rhone-Poulenc Sante, Other. Active years: 1977-1995.
Location History:
- Paris, FR (1977 - 1982)
- 94000 Creteil, FR (1985)
- Creteil, FR (1983 - 1995)
Company Filing History:
8 out of 252 
1 out of 192 
1 out of 834,411 Years Active: 1977-1995
Title: Icilio A Cavero: Innovator in Pharmaceutical Chemistry
Introduction
Icilio A Cavero is a prominent inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work primarily focuses on developing medicinal products aimed at treating various cardiovascular conditions.
Latest Patents
Cavero's latest patents include the innovative compound N-methyl-2-(3-pyridyl)-tetrahydrothio-pyran-2-carbothioamide 1-oxide. This compound is applied in the form of a racemic mixture of the 1S,2S and 1R,2R isomers or as the 1R,2R isomer itself. It is intended for the preparation of medicinal products aimed at treating coronary insufficiency. Additionally, he has developed pharmaceutical compositions containing diltiazem, which are useful for treating hypertension, cardiac insufficiency, and coronary insufficiency.
Career Highlights
Throughout his career, Icilio A Cavero has worked with notable companies, including Synthelabo. His expertise in pharmaceutical chemistry has led to advancements in treatments for cardiovascular diseases, showcasing his commitment to improving patient outcomes.
Collaborations
Cavero has collaborated with esteemed colleagues such as Salomon Z Langer and Philippe Michel Manoury. These partnerships have further enriched his research and development efforts in the pharmaceutical industry.
Conclusion
Icilio A Cavero's contributions to pharmaceutical chemistry and his innovative patents have made a significant impact on the treatment of cardiovascular conditions. His work continues to influence the field and improve the lives of many patients.